Study on the Correlation Factors of Tumour Prognosis after Intravascular Interventional Therapy

Noninvasive or minimally invasive interventional surgery was selected, and the complications were less and had no significant impact on the quality of life of patients. Tumour patients are often accompanied by cerebrovascular diseases, metabolic diseases, and other basic diseases, which more or less adversely affect the surgical efficacy of tumour. In this paper, endovascular remobilization was used to treat tumour; the basic condition of patients before operation and the interventional operation plan were introduced. Through the analysis of clinical data and prognosis evaluation results of tumour patients receiving intravascular interventional therapy, the patients were divided into good prognosis group and poor prognosis group according to the modified Rankin scale score at discharge. The relationship between gender, age, history of hypertension, tumour width, tumour size, preoperative Hunt-Hess grade, interventional surgery method, and prognosis related to intravascular interventional therapy was explored. The results showed that intravascular interventional therapy for tumour patients can obtain a good prognosis, which provides a reference for the future preoperative assessment of treatment risk and possible prognosis and provides a theoretical basis for the formulation of treatment plan to improve prognosis.

[1]  T. de Baère,et al.  Interventional Radiology for Local Immunotherapy in Oncology , 2021, Clinical Cancer Research.

[2]  Mei Liu,et al.  Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study , 2020, BMC Cancer.

[3]  Brian C. Case,et al.  Intravascular lithotripsy facilitated percutaneous endovascular intervention of the aortic arch: A single-center experience. , 2020, Cardiovascular revascularization medicine : including molecular interventions.

[4]  A. McCarthy,et al.  Catheter‐related thrombosis incidence and risk factors in adult cancer patients with central venous access devices , 2020, Internal medicine journal.

[5]  Eung Tae Kim,et al.  Prevalence and predictors of peripherally inserted central venous catheter associated bloodstream infections in cancer patients , 2020, Medicine.

[6]  W. Pabon-Ramos,et al.  Recognition and management of dermatologic complications from interventional radiology procedures. , 2019, Diagnostic and interventional imaging.

[7]  E. Soule,et al.  Finally, a Minimally Invasive Option for Intrahepatic Inferior Vena Cava Invasion by Hepatocellular Carcinoma , 2018, Gastrointestinal Tumors.

[8]  E. Campo,et al.  Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. , 2018, Blood.

[9]  Peter Y. Kim,et al.  Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field , 2018, Front. Cardiovasc. Med..

[10]  Jae C. Chang Disseminated intravascular coagulation: is it fact or fancy? , 2018, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[11]  J. Durand,et al.  Management of CAD in Patients with Active Cancer: the Interventional Cardiologists’ Perspective , 2017, Current Cardiology Reports.

[12]  M. Davies,et al.  Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. , 2017, Journal of vascular surgery. Venous and lymphatic disorders.

[13]  V. Bourcier,et al.  Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series. , 2017, Radiology.

[14]  Mei Qiang,et al.  The efficiency analysis of thrombolytic rt-PA combined with intravascular interventional therapy in patients with acute basilar artery occlusion , 2017, International journal of biological sciences.

[15]  L. Capussotti,et al.  Bleeding Recurrence and Mortality Following Interventional Management of Spontaneous HCC Rupture: Results of a Multicenter European Study , 2017, World Journal of Surgery.

[16]  C. Grines,et al.  Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue , 2016, Circulation.

[17]  S. Pascual,et al.  New advances in hepatocellular carcinoma. , 2016, World journal of hepatology.

[18]  M. Pai,et al.  Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis? , 2016, Journal of thrombosis and haemostasis : JTH.

[19]  B. Taslakian,et al.  Patient Evaluation and Preparation in Vascular and Interventional Radiology: What Every Interventional Radiologist Should Know (Part 2: Patient Preparation and Medications) , 2016, CardioVascular and Interventional Radiology.

[20]  S. Cai,et al.  Diagnosis and Treatment of Abdominal Arterial Bleeding After Radical Gastrectomy: a Retrospective Analysis of 1875 Consecutive Resections for Gastric Cancer , 2015, Journal of Gastrointestinal Surgery.

[21]  Lamine Mili,et al.  On the Definition of Cyber-Physical Resilience in Power Systems , 2015, ArXiv.